Literature DB >> 7823950

Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism.

J F Boylan1, T Lufkin, C C Achkar, R Taneja, P Chambon, L J Gudas.   

Abstract

F9 embryonic teratocarcinoma stem cells differentiate into an epithelial cell type called extraembryonic endoderm when treated with retinoic acid (RA), a derivative of retinol (vitamin A). This differentiation is presumably mediated through the actions of retinoid receptors, the RARs and RXRs. To delineate the functions of each of the different retinoid receptors in this model system, we have generated F9 cell lines in which both copies of either the RAR alpha gene or the RAR gamma gene are disrupted by homologous recombination. The absence of RAR alpha is associated with a reduction in the RA-induced expression of both the CRABP-II and Hoxb-1 (formerly 2.9) genes. The absence of RAR gamma is associated with a loss of the RA-inducible expression of the Hoxa-1 (formerly Hox-1.6), Hoxa-3 (formerly Hox-1.5), laminin B1, collagen IV (alpha 1), GATA-4, and BMP-2 genes. Furthermore, the loss of RAR gamma is associated with a reduction in the metabolism of all-trans-RA to more polar derivatives, while the loss of RAR alpha is associated with an increase in metabolism of RA relative to wild-type F9 cells. Thus, each of these RARs exhibits some specificity with respect to the regulation of differentiation-specific gene expression. These results provide an explanation for the expression of multiple RAR types within one cell type and suggest that each RAR has specific functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7823950      PMCID: PMC231962          DOI: 10.1128/MCB.15.2.843

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

Review 1.  Retinoids, homeoboxes, and growth factors: toward molecular models for limb development.

Authors:  C J Tabin
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

2.  Early retinoic acid-induced F9 teratocarcinoma stem cell gene ERA-1: alternate splicing creates transcripts for a homeobox-containing protein and one lacking the homeobox.

Authors:  G J LaRosa; L J Gudas
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

3.  Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells.

Authors:  C M Stoner; L J Gudas
Journal:  Cancer Res       Date:  1989-03-15       Impact factor: 12.701

4.  Cloning of murine alpha and beta retinoic acid receptors and a novel receptor gamma predominantly expressed in skin.

Authors:  A Zelent; A Krust; M Petkovich; P Kastner; P Chambon
Journal:  Nature       Date:  1989-06-29       Impact factor: 49.962

5.  A third human retinoic acid receptor, hRAR-gamma.

Authors:  A Krust; P Kastner; M Petkovich; A Zelent; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  Expression of cellular retinoic acid binding protein (CRABP) in Escherichia coli. Characterization and evidence that holo-CRABP is a substrate in retinoic acid metabolism.

Authors:  P D Fiorella; J L Napoli
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

7.  Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

Authors:  R P Warrell; S R Frankel; W H Miller; D A Scheinberg; L M Itri; W N Hittelman; R Vyas; M Andreeff; A Tafuri; A Jakubowski
Journal:  N Engl J Med       Date:  1991-05-16       Impact factor: 91.245

8.  Identification and spatial distribution of retinoids in the developing chick limb bud.

Authors:  C Thaller; G Eichele
Journal:  Nature       Date:  1987 Jun 18-24       Impact factor: 49.962

9.  Octamer binding proteins confer transcriptional activity in early mouse embryogenesis.

Authors:  H R Schöler; R Balling; A K Hatzopoulos; N Suzuki; P Gruss
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

10.  The late retinoic acid induction of laminin B1 gene transcription involves RAR binding to the responsive element.

Authors:  G Vasios; S Mader; J D Gold; M Leid; Y Lutz; M P Gaub; P Chambon; L Gudas
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more
  33 in total

1.  Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts.

Authors:  R Taneja; B Roy; J L Plassat; C F Zusi; J Ostrowski; P R Reczek; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells.

Authors:  C Sumi-Ichinose; H Ichinose; D Metzger; P Chambon
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Retinoic acid receptor γ (Rarg) and nuclear receptor subfamily 5, group A, member 2 (Nr5a2) promote conversion of fibroblasts to functional neurons.

Authors:  Zixiao Shi; Tianjin Shen; Yanli Liu; Yuanyuan Huang; Jianwei Jiao
Journal:  J Biol Chem       Date:  2014-01-23       Impact factor: 5.157

4.  Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment.

Authors:  R Taneja; C Rochette-Egly; J L Plassat; L Penna; M P Gaub; P Chambon
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

5.  Combinatorial knockout of RARα, RARβ, and RARγ completely abrogates transcriptional responses to retinoic acid in murine embryonic stem cells.

Authors:  Kristian B Laursen; Lorraine J Gudas
Journal:  J Biol Chem       Date:  2018-05-30       Impact factor: 5.157

6.  Radiolabeling and initial biological evaluation of [18F]KBM-1 for imaging RAR-α receptors in neuroblastoma.

Authors:  Kiran Kumar Solingapuram Sai; Bhaskar C Das; Anirudh Sattiraju; Frankis G Almaguel; Suzanne Craft; Akiva Mintz
Journal:  Bioorg Med Chem Lett       Date:  2017-02-01       Impact factor: 2.823

7.  Reexpression of retinoic acid receptor (RAR) gamma or overexpression of RAR alpha or RAR beta in RAR gamma-null F9 cells reveals a partial functional redundancy between the three RAR types.

Authors:  R Taneja; P Bouillet; J F Boylan; M P Gaub; B Roy; L J Gudas; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.

Authors:  Wenli Zhang; Zhong-Liang Deng; Liang Chen; Guo-Wei Zuo; Qing Luo; Qiong Shi; Bing-Qiang Zhang; Eric R Wagner; Farbod Rastegar; Stephanie H Kim; Wei Jiang; Jikun Shen; Enyi Huang; Yanhong Gao; Jian-Li Gao; Jian-Zhong Zhou; Jinyong Luo; Jiayi Huang; Xiaoji Luo; Yang Bi; Yuxi Su; Ke Yang; Hao Liu; Hue H Luu; Rex C Haydon; Tong-Chuan He; Bai-Cheng He
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

9.  All-trans retinoic acid directs urothelial specification of murine embryonic stem cells via GATA4/6 signaling mechanisms.

Authors:  Joshua R Mauney; Aruna Ramachandran; Richard N Yu; George Q Daley; Rosalyn M Adam; Carlos R Estrada
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

10.  Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.

Authors:  Dan Su; Lorraine J Gudas
Journal:  Biochem Pharmacol       Date:  2007-11-22       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.